Wednesday September 23, 2020

Start-up of the week: Inflection Biosciences

The figures around cancer are terrifying. In Ireland, it is the second most common cause of death, and one in three people will develop it in their lifetime.

6th July, 2013
Darren Cunningham and Michael O'Neill, co-founders of Inflection Biosciences. Photo: Keith Arkins

Inflection Biosciences

**What it does:** developing a targeted small molecule treatment for cancer


Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 8 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago